このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Long-term Health and Economic Effects of an Individualized Lifestyle Intervention (LI-PAD-Extended) (LI-PAD-EXTENDE)

2026年8月25日 更新者:Vastra Gotaland Region

Long-term Follow-up of Individualized Lifestyle Intervention Focused on Physical Activity and Diet: Effects on Weight Loss, Dietary Habits, Cardiovascular Health, Motivation, Health-related Quality of Life, and Health Economics (LI-PAD-Extended)

The goal of this clinical trial is to learn if an individualized lifestyle intervention works to improve weight, diet, physical activity, cardiovascular health, health-related quality of life, and cost-effectiveness in overweight and obese adults aged 45-65 years.

The main questions it aims to answer are:

Does the intervention lead to sustained weight loss after 18 months?

Does the intervention improve cardiovascular risk factors, metabolic markers, and health-related quality of life compared to general written advice?

Is the intervention cost-effective?

Researchers will compare the individualized lifestyle intervention to a control group that receives general written advice on physical activity and diet to see if the intervention provides greater long-term health and economic benefits.

Participants will:

Attend counseling sessions with a health promoter Take part in supervised aerobic and resistance training with a physiotherapist Use swimming facilities and participate in the Lifestyle School Access a digital health coach and the online Lifestyle Tool Complete measurements of body weight, diet, physical activity, and cardiovascular health markers (waist-to-hip ratio, blood pressure, blood lipids, fasting glucose, HbA1c, CRP, and liver enzymes) Complete assessments of resting energy expenditure, aerobic fitness, muscle strength, motivation, and health-related quality of life Provide blood samples at baseline, 6 months, and 18 months for dietary biomarker analysis Contribute data for health economic evaluation to assess cost-effectiveness

調査の概要

状態

積極的、募集していない

詳細な説明

Background Overweight and obese adults, especially those with type 2 diabetes, have increased risk of cardiovascular disease (CVD). Lifestyle interventions with physical activity (PA) and diet improve CVD risk factors, but long-term behavior change is challenging. Individualized approaches are recommended, yet rarely implemented for both PA and diet in clinical practice.

Objectives

The study evaluates whether an individualized precision health intervention:

Produces greater weight loss at 6 months (short-term) and 18 months (long-term)

Improves cardiovascular risk factors, metabolic markers, diet, PA behaviors, fitness, and psychosocial outcomes

Is feasible and cost-effective compared to standard lifestyle advice

Study Design

Randomized controlled trial with two arms:

Intervention group: Individualized precision health program

Control group: Standard lifestyle advice

Total participants: 120 (60 per group), aged 45-65 years, BMI 28-34

Exclusion: known coronary artery disease, inability to participate in lifestyle interventions, or language barriers

Intervention (LI-PAD Precision Health):

Step 1: Individual Adaptation

Adjust recommendations for medical conditions, comorbidities, medications, psychosocial factors, preferences, readiness to change, and barriers/facilitators

Step 2: Individualized Advice

PA prescription based on accelerometry, VO₂max, and muscle strength

Dietary guidance based on food intake diaries and measured resting energy expenditure (REE)

Step 3: Support for Goal Achievement

Education and skill training

Behavioral support: health promoters, group sessions, face-to-face and online coaching, apps for diet and PA, nudging

Control Group:

Standard lifestyle advice: healthy diet, ≥300 min/week moderate-intensity aerobic PA, 2 sessions/week strength training

Outcome Measures:

Primary Outcome:

Change in body weight from baseline to 6 months and 18 months

Secondary Outcomes:

BMI, waist and hip circumference

Blood pressure

Blood markers: cardiometabolic (lipids, HbA1c, cholesterol, HDL, LDL; ASAT, ALAT, ALP, GGT, hs-CRP) and dietary intake biomarkers

Cardiorespiratory fitness and muscle strength

Behavioral measures: PA (accelerometry, SGPALS), diet (MiniMeal-Q, REE)

Psychosocial outcomes: health-related quality of life (EQ5D-3L, RAND-36), motivation, self-efficacy

Cost-effectiveness analysis based on BMI and secondary outcomes

Additional Outcomes (Intervention Group):

Feasibility: attendance, compliance, participant evaluation

Barriers and facilitators to behavioral change

GPS tracking of PA and dietary behavior

Assessments:

Baseline, 6-month, and 18-month follow-ups

Anthropometry, REE, blood pressure, blood markers, fitness tests, accelerometry, questionnaires, and dietary logs

Statistical Analysis:

Multilevel mixed models for repeated measures

Linear and logistic regression for continuous and categorical variables

Structural equation modeling and partial least squares regression to explore relationships between intervention components and outcomes

Collaborators:

Sahlgrenska University Hospital/Östra: health promoters, physiotherapists, biomedical analysts

University of Gothenburg: Food and Nutrition, Sport Science, metabolomics, health economics

National and international collaborators with expertise in PA, diet, and cardiovascular health

Summary:

LI-PAD-Extended is an 18-month follow-up evaluating individualized precision health interventions. The study combines objective PA and dietary assessments with behavioral support and cost-effectiveness evaluation. This long-term follow-up allows assessment of sustained effects of precision lifestyle interventions on weight, cardiovascular risk, fitness, psychosocial outcomes, and economic efficiency.

研究の種類

介入

入学 (推定)

103

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Västra Götaland County
      • Gothenburg、Västra Götaland County、スウェーデン、416 85
        • Centre for Lifestyle Intervention

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

  • Adults aged 45-65 years at baseline of the original LI-PAD study
  • Body mass index (BMI) ≥28 and ≤34
  • Completed the original LI-PAD study
  • Able and willing to attend follow-up assessments and provide necessary data
  • Able and willing to provide informed consent

Exclusion Criteria:

  • Known coronary artery disease (clinical symptoms or earlier event)
  • Inability to understand the language used in the study
  • Inability to complete follow-up assessments at 18 months
  • Severe illness or medical condition that, in the investigator's opinion, precludes participation in follow-up assessments

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:防止
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
介入なし:標準治療
対照群は、食事に関する一般的な推奨事項(Nordic Nutrition Recommendations、2012. 栄養と身体活動を統合します。 コペンハーゲン:北欧大臣評議会、2014年)およびPA(世界保健機関。 身体活動と座りっぱなしの行動に関する世界保健機関のガイドライン、2020 年)。これには、週 300 分の中強度の有酸素運動と週 2 回の筋力トレーニングを目標とした、健康的で多様な食事が含まれます。
実験的:Individualized Lifestyle Program
The intervention group will receive (offered) an optimal prescription of physical activity and diet based on medical (comorbidities, risk profile, medications, symptoms) and psycho-social (preferences for physical activities and diet, barriers-facilitators, social support, readiness to change, accelerometry and predicted VO2-max data (Ekblom Bak ergometer test), resting energy expenditure and knowledge and skills (lifestyle education school for achieving knowledge and skills in handling change in diet and physical activity in daily life) and support (health promotors, behavioral change app, food diary app, face-to-face, phone/online coaching, physical activity (aerobic training, strength training) in group and nudging.
精密な健康

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Body Weight Change
時間枠:Baseline, 6 months, 18 months
Change from baseline in body weight measured using calibrated scales and standardized protocols.
Baseline, 6 months, 18 months

二次結果の測定

結果測定
メジャーの説明
時間枠
Change in Body Mass Index (BMI)
時間枠:Baseline, 6 months, 18 months.
Change from baseline in body mass index (BMI) measured using standard protocols.
Baseline, 6 months, 18 months.
Change in Systolic Blood Pressure
時間枠:Baseline, 6 months, 18 months
Change from baseline in systolic blood pressure measured using standardized sphygmomanometer protocols.
Baseline, 6 months, 18 months
Change in Waist Circumference
時間枠:Baseline, 6 months, 18 months
Change from baseline in waist circumference (cm) measured using standard protocols.
Baseline, 6 months, 18 months
Change in Hip Circumference
時間枠:Baseline, 6 months, 18 months
Change from baseline in hip circumference measured using standard protocols.
Baseline, 6 months, 18 months
Change in Total Cholesterol
時間枠:Baseline, 6 months, 18 months
Change from baseline in total cholesterol.
Baseline, 6 months, 18 months
Change in HDL Cholesterol
時間枠:Baseline, 6 months, 18 months
Change from baseline in high-density lipoprotein (HDL) cholesterol.
Baseline, 6 months, 18 months
Change in LDL Cholesterol
時間枠:Baseline, 6 months, 18 months
Change from baseline in low-density lipoprotein (LDL) cholesterol.
Baseline, 6 months, 18 months
Change in Triglycerides
時間枠:Baseline, 6 months, 18 months
Change from baseline in triglycerides
Baseline, 6 months, 18 months
Change in HbA1c
時間枠:Baseline, 6 months, 18 months
Change from baseline in glycated hemoglobin (HbA1c)
Baseline, 6 months, 18 months
Change in Aspartate Aminotransferase (ASAT)
時間枠:Baseline, 6 months, 18 months
Change from baseline in aspartate aminotransferase (ASAT)
Baseline, 6 months, 18 months
Change in Alanine Aminotransferase (ALAT)
時間枠:Baseline, 6 months, 18 months
Change from baseline in alanine aminotransferase (ALAT).
Baseline, 6 months, 18 months
Change in High-Sensitivity C-Reactive Protein (hs-CRP)
時間枠:Baseline, 6 months, 18 months
Change from baseline in high-sensitivity C-reactive protein (hs-CRP).
Baseline, 6 months, 18 months
Change in Dietary Biomarkers (Metabolomics)
時間枠:Baseline, 6 months, 18 months
Change from baseline in dietary biomarkers assessed using metabolomics. Biomarkers reflect intake of selected food groups (e.g., whole grains, dairy products, legumes, and sugars) and are quantified using validated analytical methods and expressed as relative concentrations or standardized scores.
Baseline, 6 months, 18 months
Change in Cardiorespiratory Fitness (VO₂max)
時間枠:Baseline, 6 months, 18 months
Change from baseline in cardiorespiratory fitness (VO₂max) (mL/kg/min) assessed using the Ekblom-Bak cycle test.
Baseline, 6 months, 18 months
Change in Muscle Strength (Handgrip Strength)
時間枠:Baseline, 6 months, 18 months
Change from baseline in muscle strength (kg) assessed by handgrip strength using a Jamar hand dynamometer.
Baseline, 6 months, 18 months
Change in Mean Daily Physical Activity Counts as Assessed by Accelerometry
時間枠:Baseline, 6 months, 18 months
Change from baseline in physical activity assessed using accelerometry, summarized as mean daily activity counts at 6 and 18 months.
Baseline, 6 months, 18 months
Change in Self-Reported Physical Activity (Saltin-Grimby Physical Activity Level Scale, SGPALS)
時間枠:Baseline, 6 months, 18 months
Change from baseline in physical activity assessed using the Saltin-Grimby Physical Activity Level Scale (SGPALS).
Baseline, 6 months, 18 months
Change in Resting Energy Expenditure (REE)
時間枠:Baseline, 6 months, 18 months
Change from baseline in resting energy expenditure (REE) (kcal/day).
Baseline, 6 months, 18 months
Change in Dietary Intake (MiniMeal-Q questionnaire)
時間枠:Baseline, 6 months, 18 months
Change from baseline in dietary intake assessed using the MiniMeal-Q questionnaire.
Baseline, 6 months, 18 months
Change in Health-Related Quality of Life (EQ-5D-3L)
時間枠:Baseline, 6 months, 18 months
Change from baseline in health-related quality of life assessed using the EQ-5D-3L index.
Baseline, 6 months, 18 months
Motivation for Lifestyle Change
時間枠:18 months
Motivation assessed at 18 months using a standardized questionnaire. The assessment reflects the preceding 12 months (i.e., the period between the 6-month and 18-month follow-up).
18 months
Perceived Self-Efficacy
時間枠:18 months
Self-efficacy assessed at 18 months using a standardized questionnaire. The assessment reflects the preceding 12 months (i.e., the period between the 6-month and 18-month follow-up).
18 months
Cost-Effectiveness (Incremental Cost-Effectiveness Ratio, ICER)
時間枠:18 months
Incremental cost-effectiveness ratio (ICER) comparing individualized lifestyle intervention to standard advice, expressed as cost per quality-adjusted life year (QALY) gained.
18 months
Motivation for Maintaining Lifestyle Change
時間枠:18 months
Motivation for maintaining lifestyle change, assessed at 18 months using a single-item question rated on a scale from 0 (not at all important) to 10 (extremely important). Higher scores indicate greater motivation. The assessment reflects the preceding 12 months (i.e., the period between the 6-month and 18-month follow-up).
18 months
Perceived Autonomous Motivation for Weight Management
時間枠:18 months
Autonomous motivation for weight management, assessed at 18 months using a study-specific multi-item questionnaire. Items reflecting intrinsic motivation are rated on a 5-point Likert scale (1 = not at all true to 5 = completely true) and aggregated into a mean score. Higher scores indicate greater autonomous motivation. The assessment reflects the preceding 12 months (i.e., the period between the 6-month and 18-month follow-up).
18 months
Perceived Controlled Motivation for Weight Management
時間枠:18 months
Controlled motivation for weight management, assessed at 18 months using a study-specific multi-item questionnaire. Items reflecting external and introjected regulation are rated on a 5-point Likert scale (1 = not at all true to 5 = completely true) and aggregated into a mean score. Higher scores indicate greater controlled motivation. The assessment reflects the preceding 12 months (i.e., the period between the 6-month and 18-month follow-up).
18 months
Perceived Importance of Individualization in Lifestyle Intervention
時間枠:18 months
Participant-reported perceived importance of individualized components of the lifestyle intervention for maintaining weight stability or weight loss, assessed at 18 months using a study-specific single-item question rated on a 5-point Likert scale (1 = not at all to 5 = completely). Higher scores indicate greater perceived importance. The assessment reflects the preceding 12 months (i.e., the period between the 6-month and 18-month follow-up).
18 months
Perceived Appropriateness of Study Duration
時間枠:18 months
Participant-reported perception of study duration in relation to achieving sustainable lifestyle change, assessed at 18 months using a single-item categorical question with response options: "too short," "somewhat short," "appropriate," "somewhat long," and "too long." The assessment reflects the preceding 12 months (i.e., the period between the 6-month and 18-month follow-up).
18 months
Perceived Importance of Lifestyle Intervention Components
時間枠:18 months
Participant-reported perceived importance of different components of the lifestyle intervention (e.g., counseling sessions, mobile application, gym access, supervised exercise, and educational sessions) for maintaining weight stability or weight loss. Each component is rated on a 5-point Likert scale (1 = not at all to 5 = completely). Items are aggregated into a mean score based on available responses. Higher scores indicate greater perceived importance of the intervention components. Participants who did not engage in a specific component are excluded from that item in the score calculation.
18 months
Perceived Psychological Capabilities for Lifestyle Change
時間枠:18 months
Psychological capabilities for lifestyle change, assessed at 18 months using a study-specific multi-item questionnaire. Items related to self-efficacy, stress management, behavioral awareness, and ability to initiate and maintain behavior change are rated on a 5-point Likert scale (1 = not at all to 5 = completely) and aggregated into a mean score. Higher scores indicate greater perceived capability for lifestyle change. The assessment reflects the preceding 12 months (i.e., the period between the 6-month and 18-month follow-up).
18 months
Importance of Behavioral Strategies for Weight Management
時間枠:18 months
Participant-reported importance of behavioral strategies for weight management, assessed at 18 months using a study-specific multi-item questionnaire. Items related to dietary awareness, meal planning, portion control, weight monitoring, and self-monitoring behaviors are rated on a 5-point Likert scale (1 = not at all important to 5 = very important) and aggregated into a mean score. Higher scores indicate greater perceived importance of behavioral strategies. The assessment reflects the preceding 12 months (i.e., the period between the 6-month and 18-month follow-up).
18 months
Perceived Positive Social Support for Weight Management
時間枠:18 months
Perceived positive social support for weight management, assessed at 18 months using a study-specific multi-item questionnaire. Items related to emotional and practical support from close contacts and external support services are rated on a 5-point Likert scale (1 = not at all to 5 = completely) and aggregated into a mean score. Higher scores indicate greater perceived positive social support. The assessment reflects the preceding 12 months (i.e., the period between the 6-month and 18-month follow-up).
18 months
Perceived Negative Social Influence on Weight Management
時間枠:18 months
Perceived negative social influence on weight management, assessed at 18 months using a study-specific multi-item questionnaire. Items related to negative comments and social norms are rated on a 5-point Likert scale (1 = not at all to 5 = completely) and aggregated into a mean score. Higher scores indicate greater negative social influence. The assessment reflects the preceding 12 months (i.e., the period between the 6-month and 18-month follow-up).
18 months
Perceived Environmental Support for Healthy Lifestyle
時間枠:18 months
Perceived environmental support for maintaining a healthy lifestyle, assessed at 18 months using a study-specific multi-item questionnaire. Items related to home environment, workplace environment, and commuting environment in relation to physical activity and healthy eating are rated on a 5-point Likert scale (1 = not at all to 5 = completely) and aggregated into a mean score. Higher scores indicate greater perceived environmental support for healthy lifestyle behaviors. The assessment reflects the preceding 12 months (i.e., the period between the 6-month and 18-month follow-up).
18 months
Perceived Financial Support for Healthy Lifestyle
時間枠:18 months
Perceived financial support for maintaining a healthy lifestyle, assessed at 18 months using a study-specific multi-item questionnaire. Items related to financial ability to engage in physical activity and maintain a healthy diet are rated on a 5-point Likert scale (1 = not at all to 5 = completely) and aggregated into a mean score. Higher scores indicate greater perceived financial support for healthy lifestyle behaviors. The assessment reflects the preceding 12 months (i.e., the period between the 6-month and 18-month follow-up).
18 months

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:Mats Börjesson, Professor、University of Gothenburg, Sahlgrenska University Hospital

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2025年8月11日

一次修了 (実際)

2026年5月25日

研究の完了 (推定)

2027年12月31日

試験登録日

最初に提出

2026年2月16日

QC基準を満たした最初の提出物

2026年5月19日

最初の投稿 (実際)

2026年5月22日

学習記録の更新

投稿された最後の更新 (実際)

2026年8月28日

QC基準を満たした最後の更新が送信されました

2026年8月25日

最終確認日

2026年8月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

Individual participant data will not be shared publicly. Data from LI-PAD-Extended will be used solely for analysis by the study team.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する